It's quick, safe, and relatively painless, and if interventional radiologists want to own it, they'd better step up quickly: Endovenous laser treatment of varicose veins is poised to take off, according to researchers at Cornell University. A two-year follow-up of 97 treated limbs showed a 6% recurrence rate, compared with 10% or higher recurrence that was reported for surgery, radio-frequency ablation, and transcatheter sclerotherapy.
It's quick, safe, and relatively painless, and if interventional radiologists want to own it, they'd better step up quickly: Endovenous laser treatment of varicose veins is poised to take off, according to researchers at Cornell University. A two-year follow-up of 97 treated limbs showed a 6% recurrence rate, compared with 10% or higher recurrence that was reported for surgery, radio-frequency ablation, and transcatheter sclerotherapy.
The U.S. study was presented at this year's 15th annual International Symposium on Endovascular Therapy. It showed that laser treatment can be performed in an outpatient setting.
"Most of the people qualified to perform this procedure should be interventional radiologists, but over the next couple of years there will be thousands of physicians doing it, including vascular and general surgeons and even dermatologists," said Dr. Robert Min, coauthor and director of Cornell's new vascular center.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.